EUROPE PMC INGESTION ENGINE PYTORCH TRANSFORMER PIPELINE

Literature is vast. Connections are invisible. We illuminate repurposing pathways.

Bane mines peer-reviewed medical publications to construct traceable, multi-hop knowledge graphs. Extracting direct mechanism-of-action chains from published papers—preserving opposing trials without generative hallucinations.

Architecture FastAPI + Flutter Client
NER Model Bio-NER Token Classifier
Relation Extraction Glasgow-AI4BioMed Model
Evidence Provenance Sentence-Level PMIDs & DOIs

Billions spent discovering new molecules. Decades of clinical signals left unconnected.

Modern biomedical research is siloed across millions of isolated abstracts. Significant computational repurposing signals are already documented in published trials, waiting for structural synthesis.

PHASE I — THE INFORMATION CHASM

Unstructured text traps 85% of biological linkages.

Standard keyword queries on PubMed return long bibliographies without resolving causal pharmacological links. Researchers are forced to manually correlate drug affinities with distant pathway mutations.

PHASE II — THE HALLUCINATION RISK

Generic LLMs collapse nuance and suppress negative trials.

Generative chat tools summarize research by smoothing over contradictions. In translational medicine, limiting trials and negative toxicity markers are as vital as positive efficacy claims.

Discovering repurposing opportunities through Swanson's ABC Model.

Bane mines literature for approved drugs and their biological targets. By establishing transitive graph linkages (A -> B -> C), we surface high-impact secondary repurposing opportunities without speculative guesswork.

REPURPOSING METHODOLOGY:
STEP 01 / APPROVED DRUG
Node A: Existing Drug
Approved Molecule / Chemical Entity
INHIBITS / MODULATES
STEP 02 / BIOLOGICAL TARGET
Node B: Biological Target
Gene / Protein / Enzyme Bridge
CAUSES / DRIVES
STEP 03 / SECONDARY INDICATION
Node C: Target Disease
Secondary Disease Indication
EMERGENT LINK
STEP 04 / CANDIDATE SIGNAL
Repurposing Signal (A → C)
Transitive Hypothesis Dossier
COMPOSITE SIGNAL SCORE CALCULATION

Swanson's A → B → C Model: If Drug A modulates Target B, and Target B is a causal driver in Disease C, an indirect repurposing signal (A → C) is inferred and scored across literature citations.

Mechanistic 35%
Target-binding traversal confidence
Clinical 25%
Disease causality validation
Literature 20%
PubMed extraction frequency
Novelty 20%
Transitive separation from prior art
89 Signal Score (0–100)

The Researcher's Mobile Workbench

Explore the Bane client application interface. Navigate through the screens below using the arrow controls.

Bane Mobile Application Screen
01 / 15

Full-stack computational intelligence, from abstract to candidate dossier.

[01]

Europe PMC REST Ingestion

Automated retrieval with query expansion, keyword relevancy filters, and deduplication across millions of peer-reviewed articles.

[02]

Dual Transformer Models

Fine-tuned Named Entity Recognition (NER) paired with token-level relation extraction classifying directional biological verbs.

[03]

NetworkX Graph Topology

Constructs interactive multi-hop knowledge graphs exported to PyVis HTML for webview inspection and topological analysis.

[04]

Scored Signals Workbench

Ranks candidate repurposing opportunities via composite confidence scoring, separating statistical priority from clinical proof.

[05]

Active Literature Surveillance

Real-time alert feeds that monitor emerging publications for target mutations, clinical trials, and newly extracted candidate signals.

[06]

Cross-Platform Flutter Client

High-performance research client running natively at 60fps across iOS, Android, Windows Desktop, macOS, and Web.